

Examination of Clinical Trial Costs and Barriers for Drug Development. 4.3 Difficulties in Recruiting and Retaining Participants
In interviews, expert consultants and representatives from pharmaceutical and biotechnology companies and CROs cited patient recruitment as one of the most significant barriers to conducting clinical trials in the United States. Failure to recruit sufficient numbers of patients can result in costly delays or even cancellation of the entire trial (